About this trial
Observational prospective single-center, non-profit study. Primary objective of the study: To determine if the hypotensive phenotype, defined as one episode of daytime systolic blood pressure (SBP) \<90 mmHg (or two episodes of daytime SBP \<90 mmHg, if mean 24 h SBP is \<125 mmHg) detected at Ambulatory Blood Pressure Monitoring (ABPM) is associated with adverse events at follow up (death, hospitalization, falls, emergency room admission for uncontrolled hypertension, major cardiovascular events)
Eligibility criteria
Qualifiers
Age ≥ 75 years
Diagnosis of hypertension according to the criteria of the European Society of Cardiology guidelines [Williams 2018]
Consent of the patient (or legal representative) to participate in the study
Disqualifiers
Refusal of the patient or his/her legal representative
Life expectancy of less than 6 months
Trial design
Treatments tested in this trial
- Diagnostic tests and questionnaires